CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Our studies demonstrated that blocking of SHP-1 by SHP-1 shRNA (Fig. 5J, K) attenuated Baicalein-mediated inhibition of JAK2/STAT5 signaling in both CML CD34+ cells in co-culture model.